SURVIVAL OF BARICITINIB VS ANTI-TNF AS THE FIRST BIOLOGICAL DRUG IN PATIENTS WITH RHEUMATOID ARTHRITIS, IN CLINICAL PRACTICE: RESULTS OF A LOCAL REGISTRY

Por: Rosas, J, Pons, A, Barber, X, Senabre-Gallego, J, Soler, G, Soler-Giner, E, Bernal J, Raga, A, Raya-Santos, C, Cortes-Quiroz, J, Betoret, M and Garcia-Gomez, J

---

Publicada: 1 jun 2022

---

---

Filiaciones:
:
 Hosp Marina Baixa, Rheumatol, Alicante, Spain

:
 Hosp Marina Baixa, Rheumatol, Alicante, Spain

:
 Univ Miguel Hernandez Elche, CIO, Elche, Spain

:
 Hosp Marina Baixa, Rheumatol, Alicante, Spain

:
 Hosp Marina Baixa, Rheumatol, Alicante, Spain

:
 Hosp Marina Baixa, Pharm, Alicante 03570, Spain

Bernal J:
 Hosp Marina Baixa, Rheumatol, Alicante, Spain

:
 Hosp Marina Baixa, Pharm, Alicante 03570, Spain

:
 Hosp Marina Baixa, Rheumatol, Alicante, Spain

:
 Hosp Marina Baixa, Rheumatol, Alicante, Spain

:
 Hosp Marina Baixa, Rheumatol, Alicante, Spain